A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy

A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy

Kidney allograft rejection is associated with infiltration of inflammatory CD11b+ leukocytes. A CD11b agonist leukadherin-1 (LA1) increases leukocyte adhesion, preventing their transmigration and tissue recruitment in vivo. Here, we test the extent to which LA1-mediated activation of CD11b/CD18 enha...

Full description

Bibliographic Details
Main Authors: Khan, Samia Q., Guo, Lingling, Cimbaluk, David J., Elshabrawy, Hatem, Faridi, Mohd Hafeez, Jolly, Meenakshi, George, James F., Agarwal, Anupam, Gupta, Vineet
Format: Online
Language:English
Published: Frontiers Media S.A. 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291902/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291902/

Similar Items